Dynamiker Biotechnology (Tianjin) Co., Ltd.

Dynamiker Influenza A+B Ag Rapid Test

The number of live influenza surveillance cases worldwide reached a peak in nearly 10 years at the end of 2022, and has been stable at a low level since February 2023, with the main prevalent strain being type A.

It is intended for detection of influenza A & B viral nucleoprotein antigens in samples from individuals suspected of respiratory viral infection.

Contact Us

Specification


CatalogueDNK-2103-1
MethodLFA
Specification20 tests
SampleNasal/Throat Swabs
Storage2-30℃




Procedure

Interpretation

Get Touch With Dynamiker Now!
Send Us a Message
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept